Private Equity Round - Emil Pharmaceutical

Private Equity Round - Emil Pharmaceutical

Investment Firm

Overview

Emil Pharmaceutical is responsible for creating, producing, and selling medications of a quality that is recognised worldwide.

Announced Date

Apr 25, 2023

Funding Type

Private Equity

Highlights

Location

India, Asia

Social

Investor Lead

Somerset Indus Capital Partners

Somerset Indus Capital Partners

Somerset Indus Capital Partners is a private_equity firm.

Participant Investors

1

Investor Name
Participant InvestorSomerset Indus Capital Partners

Round Details and Background

Emil Pharmaceutical raised $14635602 on 2023-04-25 in Private Equity Round

Emil Pharmaceutical is responsible for creating, producing, and selling medications of a quality that is recognised worldwide.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 25, 2023
Private Equity Round - Emil Pharmaceutical
1-14.6M
Apr 25, 2023
Secondary Market - Emil Pharmaceutical
-3.7M

Recent Activity

There is no recent news or activity for this profile.